Literature DB >> 6707149

Determination of primaquine in biological fluids by reversed-phase high-performance liquid chromatography.

S A Ward, G Edwards, M L Orme, A M Breckenridge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6707149     DOI： 10.1016/s0378-4347(00)83337-x

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  8 in total

1.  Increased bioavailability of primaquine using poly(ethylene oxide) matrix extended-release tablets administered to beagle dogs.

Authors:  C D Bertol; P R Oliveira; G Kuminek; G S Rauber; H K Stulzer; M A S Silva
Journal:  Ann Trop Med Parasitol       Date:  2011-10

2.  Pharmacokinetics of primaquine in man. II. Comparison of acute vs chronic dosage in Thai subjects.

Authors:  S A Ward; G W Mihaly; G Edwards; S Looareesuwan; R E Phillips; P Chanthavanich; D A Warrell; M L Orme; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

3.  Simultaneous and enantiospecific quantification of primaquine and carboxyprimaquine in human plasma using liquid chromatography-tandem mass spectrometry.

Authors:  Warunee Hanpithakpong; Nicholas P J Day; Nicholas J White; Joel Tarning
Journal:  Malar J       Date:  2022-06-03       Impact factor: 3.469

Review 4.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

5.  Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite.

Authors:  G W Mihaly; S A Ward; G Edwards; M L Orme; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

6.  Pharmacokinetics of primaquine in patients with P. vivax malaria.

Authors:  S C Bhatia; Y S Saraph; S N Revankar; K J Doshi; E D Bharucha; N D Desai; A B Vaidya; D Subrahmanyam; K C Gupta; R S Satoskar
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size.

Authors:  G W Mihaly; S A Ward; G Edwards; D D Nicholl; M L Orme; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

8.  Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria.

Authors:  J Kevin Baird; Melva Louisa; Rintis Noviyanti; Lenny Ekawati; Iqbal Elyazar; Decy Subekti; Krisin Chand; Anggi Gayatri; Saraswati Soebianto; Chelzie Crenna-Darusallam; Dwi Djoko; Bambang Dwi Hasto; Dubel Meriyenes; David Wesche; Erni J Nelwan; Inge Sutanto; Herawati Sudoyo; Rianto Setiabudy
Journal:  JAMA Netw Open       Date:  2018-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.